QUANTINUUM FILES FOR IPO AMID HEAVY LOSSES
AI DESK■ 1 MIN READ
SAT, MAY 9, 2026■ AI-SUMMARIZED FROM 2 SOURCES ▸ TIMELINE
Honeywell-backed quantum computing firm Quantinuum filed for a US IPO while reporting a $136.6M net loss on just $5.2M in revenue for Q1. Sources indicate the company could raise $1.5B or more.
Quantinuum, the quantum computing venture backed by industrial conglomerate Honeywell International, entered the public markets race with a filing that underscores the sector's current economics.
The company reported a net loss of $136.6M against quarterly revenue of $5.2M for the three months ended March 31, reflecting the typical cash burn rate of early-stage quantum computing firms developing hardware and software.
People familiar with the matter told Bloomberg the IPO could generate $1.5B or more in capital. The exact offering size and valuation remain undisclosed.
Quantinuum, formed through Honeywell's quantum division, counts among a wave of quantum companies seeking public funding as the sector attracts investor attention despite remaining commercially nascent. Other quantum firms including IonQ and Rigetti have previously gone public through SPAC mergers.
The IPO represents a significant validation moment for quantum computing, though investors will scrutinize paths to profitability in a field still years away from widespread commercial applications.
■ MORE FROM THE STARTUPS DESK
Triomics, an AI platform automating data-heavy tasks for oncologists, secured $22M in Series B funding. The raise follows a $15M Series A in 2024.
18H AGO— AI Desk
Xcena secured $135 million in Series B funding at a $570 million valuation for its MX1 chip, which handles data orchestration and KV cache management directly within memory modules.
18H AGO— AI Desk
Pittsburgh-based Gray Swan, which stress-tests AI models for frontier labs, secured $40M in Series A funding at a $200M valuation. The round was co-led by Wing VC and Madrona.
YESTERDAY— AI Desk
H1, a healthcare SaaS startup, secured $40 million in funding from CVS Health. The investment signals continued investor confidence in specialized software platforms despite AI disruption concerns.
YESTERDAY— Industry Desk